Skip to main content
Clinical Trials/NCT06099808
NCT06099808
Enrolling By Invitation
Not Applicable

Randomized Evaluation of Audit and Feedback Intervention to Promote Pharmacist Heart Failure Medication Titration in Veterans Affairs Sierra Pacific Network

Stanford University1 site in 1 country110 target enrollmentNovember 20, 2023
ConditionsHeart Failure

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure
Sponsor
Stanford University
Enrollment
110
Locations
1
Primary Endpoint
Number of monthly heart failure medication adjustment encounters
Status
Enrolling By Invitation
Last Updated
2 years ago

Overview

Brief Summary

This is a randomized quality improvement project to evaluate the impact of an audit and feedback intervention to motivate pharmacists to provide heart failure (HF) medication management to patients in the Veterans Health Administration (VHA) Sierra Pacific region (VISN 21). The results of this project could provide guidance for how to successfully scale a pharmacist-based HF remote management program in the VHA more broadly.

Pharmacists providing clinical care as part of Patient Aligned Care Team (PACT) within VHA VISN 21 will be included. Pharmacists will be randomized to one of 3 arms in a 1:1:2 ratio: (1) monthly audit and feedback of HF medication titration activities (AF) vs. (2) educational resources and monthly notification of HF medication titration actions in addition to a list of potential patients for HF optimization (AF+) vs. (3) usual care without audit and feedback (UC). Pharmacists across all three arms will be given access to shared educational resources on HF pharmacist care and educational webinars. Six months after the intervention, rates of pharmacist HF medication titration encounters will be compared among the 3 groups.

Registry
clinicaltrials.gov
Start Date
November 20, 2023
End Date
September 30, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Paul A. Heidenreich

Professor of Medicine

Stanford University

Eligibility Criteria

Inclusion Criteria

  • Clinical pharmacists in the Veterans Health Administration that provide Patient Aligned Care Team (PACT) care in VA Sierra Pacific Network (VISN 21)

Exclusion Criteria

  • Excluded per pharmacist supervisor decision

Outcomes

Primary Outcomes

Number of monthly heart failure medication adjustment encounters

Time Frame: 2 months post-randomization to 6 months post-randomization

Encounters in which pharmacist adjusted heart failure medications

Secondary Outcomes

  • Beta-blocker therapy(At 6 months post randomization)
  • Number of new patients with pharmacist HF management(Within 6 months post-randomization)
  • Guideline medical therapy score(At 6 months post randomization)
  • Renin-angiotensin system inhibitor (RASI) therapy(At 6 months post randomization)
  • Percentage of heart failure patients with medication management by pharmacist(Within 6 months post-randomization)
  • Angiotensin receptor neprilysin inhibitor (ARNI) therapy(At 6 months post randomization)
  • Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) therapy(At 6 months post randomization)
  • Mineralocorticoid receptor antagonist (MRA) therapy(At 6 months post randomization)

Study Sites (1)

Loading locations...

Similar Trials